Sistema nazionale linee guida-ISS: La terapia del diabete mellito di tipo 2. LG multisocietaria
SID – Società Italiana di Diabetologia e Delle Malattie del Metabolismo
AMD – Associazione Medici Diabetologi
28/10/2025
Leggi
Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies
Colombijn JMT, de Leijer JF, Visseren FLJ, et al.
Diabetologia. Pub. online 21 Oct 2025.
Leggi
Safety and glycaemic control during exercise with the MiniMed™ 780G: a narrative review of evidence from lab to real world
Basset-Sagarminaga J, De Block C, Nørgaard K, et al.
Diabetes Obes Metab. Pub. online 19 Oct 2025.
Leggi
Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)
Fagher K, Eeg-Olofsson K, Arnqvist H, et al.
Diabetologia. Pub. online 14 Oct 2025.
Leggi
Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes
Davoodian N, Lotfaliany M, Huxley RR, et al.
Diabetologia. Pub. online 18 Oct 2025.
Leggi
Long-term effects of dietary protein and carbohydrate quality on prediabetes remission: results from the PREVIEW randomised multinational diabetes prevention trial
Zhu R, Guo J, Huttunen-Lenz M, et al.
Diabetologia. Pub. online 15 Oct 2025.
Leggi
Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes
Tangri N, Singh R, Chen Y, et al.
BMJ Open Diabetes Res Care. Pub. online 15 Oct 2025.
Leggi
Insights into the effective use of the Smart MDI system: data from the first 1852 type 1 diabetes users
Laurenzi A, Edd SN, Adolfsson P, et al.
Diabet Med. Pub. online 13 Oct 2025.
Leggi